Advertisement

Topics

Hikma Pharmaceuticals posts loss after US write-down

04:27 EDT 14 Mar 2018 | Proactive Investors

Hikma has shed two-thirds of its value over the past year due to product setbacks and a profit warning in August.

Original Article: Hikma Pharmaceuticals posts loss after US write-down

NEXT ARTICLE

More From BioPortfolio on "Hikma Pharmaceuticals posts loss after US write-down"

Advertisement
Quick Search
Advertisement
Advertisement